Met Life Investment Management, LLC Cardlytics, Inc. Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Cardlytics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 18,016 shares of CDLX stock, worth $147,911. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,016Holding current value
$147,911% of portfolio
0.0%Shares
33 transactions
Others Institutions Holding CDLX
# of Institutions
165Shares Held
35.7MCall Options Held
739KPut Options Held
1.29M-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$52.3 Million8.28% of portfolio
-
Black Rock Inc. New York, NY2.87MShares$23.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.29MShares$18.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.21MShares$18.2 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2MShares$16.4 Million2.47% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $270M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...